CSF2 and Sepsis: Yet, in a monocyte HLA-DR guided pilot study immunotherapy with GM-CSF in the immunosuppressive phase of sepsis resulted in the reversal of the characteristic monocyte deactivation by restoring TLR-2 and -4 induced cytokine production [9].